# Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

> **NCT00092599** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 410 (actual)

## Conditions studied

- Hypercholesterolemia
- Coronary Disease

## Interventions

- **DRUG:** MK0653, ezetimibe
- **DRUG:** Comparator: ezetimibe, placebo

## Key facts

- **NCT ID:** NCT00092599
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2004-06
- **Final completion:** 2004-07
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092599, "Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00092599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*